nodes	percent_of_prediction	percent_of_DWPC	metapath
Tinidazole—CYP3A4—Cytarabine—lymphatic system cancer	0.173	0.318	CbGbCtD
Tinidazole—CYP3A4—Teniposide—lymphatic system cancer	0.17	0.313	CbGbCtD
Tinidazole—CYP3A4—Mitoxantrone—lymphatic system cancer	0.119	0.219	CbGbCtD
Tinidazole—CYP3A4—Vincristine—lymphatic system cancer	0.0819	0.151	CbGbCtD
Tinidazole—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00207	0.00453	CcSEcCtD
Tinidazole—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.00206	0.00453	CcSEcCtD
Tinidazole—Stomatitis—Bleomycin—lymphatic system cancer	0.00204	0.00446	CcSEcCtD
Tinidazole—Aspartate aminotransferase increased—Vincristine—lymphatic system cancer	0.00203	0.00446	CcSEcCtD
Tinidazole—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00202	0.00443	CcSEcCtD
Tinidazole—Malaise—Fludarabine—lymphatic system cancer	0.00201	0.0044	CcSEcCtD
Tinidazole—Hyperhidrosis—Teniposide—lymphatic system cancer	0.002	0.00438	CcSEcCtD
Tinidazole—Leukopenia—Fludarabine—lymphatic system cancer	0.00199	0.00437	CcSEcCtD
Tinidazole—Pruritus—Mechlorethamine—lymphatic system cancer	0.00198	0.00435	CcSEcCtD
Tinidazole—Aspartate aminotransferase increased—Mitoxantrone—lymphatic system cancer	0.00198	0.00434	CcSEcCtD
Tinidazole—Anorexia—Teniposide—lymphatic system cancer	0.00197	0.00432	CcSEcCtD
Tinidazole—Convulsion—Fludarabine—lymphatic system cancer	0.00193	0.00423	CcSEcCtD
Tinidazole—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00192	0.0042	CcSEcCtD
Tinidazole—Neutropenia—Carmustine—lymphatic system cancer	0.00191	0.00419	CcSEcCtD
Tinidazole—Arthralgia—Fludarabine—lymphatic system cancer	0.00189	0.00415	CcSEcCtD
Tinidazole—Myalgia—Fludarabine—lymphatic system cancer	0.00189	0.00415	CcSEcCtD
Tinidazole—Discomfort—Fludarabine—lymphatic system cancer	0.00187	0.0041	CcSEcCtD
Tinidazole—Hypoaesthesia—Bleomycin—lymphatic system cancer	0.00187	0.00409	CcSEcCtD
Tinidazole—Dyspnoea—Teniposide—lymphatic system cancer	0.00184	0.00404	CcSEcCtD
Tinidazole—Confusional state—Fludarabine—lymphatic system cancer	0.00183	0.00401	CcSEcCtD
Tinidazole—Dysuria—Vincristine—lymphatic system cancer	0.00182	0.004	CcSEcCtD
Tinidazole—Neutropenia—Vincristine—lymphatic system cancer	0.00182	0.004	CcSEcCtD
Tinidazole—Decreased appetite—Teniposide—lymphatic system cancer	0.0018	0.00394	CcSEcCtD
Tinidazole—Neuropathy peripheral—Carmustine—lymphatic system cancer	0.00179	0.00392	CcSEcCtD
Tinidazole—Vomiting—Mechlorethamine—lymphatic system cancer	0.00178	0.00391	CcSEcCtD
Tinidazole—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00178	0.0039	CcSEcCtD
Tinidazole—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00178	0.0039	CcSEcCtD
Tinidazole—Neutropenia—Mitoxantrone—lymphatic system cancer	0.00178	0.00389	CcSEcCtD
Tinidazole—Stomatitis—Carmustine—lymphatic system cancer	0.00178	0.00389	CcSEcCtD
Tinidazole—Urinary tract infection—Carmustine—lymphatic system cancer	0.00177	0.00388	CcSEcCtD
Tinidazole—Rash—Mechlorethamine—lymphatic system cancer	0.00177	0.00387	CcSEcCtD
Tinidazole—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00177	0.00387	CcSEcCtD
Tinidazole—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00176	0.00385	CcSEcCtD
Tinidazole—Flushing—Bleomycin—lymphatic system cancer	0.00174	0.00381	CcSEcCtD
Tinidazole—Anorexia—Fludarabine—lymphatic system cancer	0.00173	0.00379	CcSEcCtD
Tinidazole—Neuropathy peripheral—Vincristine—lymphatic system cancer	0.00171	0.00374	CcSEcCtD
Tinidazole—Feeling abnormal—Teniposide—lymphatic system cancer	0.0017	0.00373	CcSEcCtD
Tinidazole—Stomatitis—Vincristine—lymphatic system cancer	0.0017	0.00372	CcSEcCtD
Tinidazole—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00169	0.00371	CcSEcCtD
Tinidazole—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00169	0.0037	CcSEcCtD
Tinidazole—Sweating—Vincristine—lymphatic system cancer	0.00167	0.00366	CcSEcCtD
Tinidazole—Nausea—Mechlorethamine—lymphatic system cancer	0.00167	0.00365	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00165	0.00363	CcSEcCtD
Tinidazole—Stomatitis—Mitoxantrone—lymphatic system cancer	0.00165	0.00362	CcSEcCtD
Tinidazole—Urinary tract infection—Mitoxantrone—lymphatic system cancer	0.00165	0.00361	CcSEcCtD
Tinidazole—Urticaria—Teniposide—lymphatic system cancer	0.00164	0.0036	CcSEcCtD
Tinidazole—Glossitis—Methotrexate—lymphatic system cancer	0.00164	0.00359	CcSEcCtD
Tinidazole—Abdominal pain—Teniposide—lymphatic system cancer	0.00163	0.00358	CcSEcCtD
Tinidazole—Body temperature increased—Teniposide—lymphatic system cancer	0.00163	0.00358	CcSEcCtD
Tinidazole—Paraesthesia—Fludarabine—lymphatic system cancer	0.00163	0.00357	CcSEcCtD
Tinidazole—Hypoaesthesia—Carmustine—lymphatic system cancer	0.00163	0.00357	CcSEcCtD
Tinidazole—Sweating—Mitoxantrone—lymphatic system cancer	0.00162	0.00356	CcSEcCtD
Tinidazole—Dyspnoea—Fludarabine—lymphatic system cancer	0.00162	0.00355	CcSEcCtD
Tinidazole—Dyspepsia—Fludarabine—lymphatic system cancer	0.0016	0.0035	CcSEcCtD
Tinidazole—Decreased appetite—Fludarabine—lymphatic system cancer	0.00158	0.00346	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00157	0.00344	CcSEcCtD
Tinidazole—Fatigue—Fludarabine—lymphatic system cancer	0.00157	0.00343	CcSEcCtD
Tinidazole—Hypoaesthesia—Vincristine—lymphatic system cancer	0.00155	0.00341	CcSEcCtD
Tinidazole—Constipation—Fludarabine—lymphatic system cancer	0.00155	0.0034	CcSEcCtD
Tinidazole—Urinary tract disorder—Vincristine—lymphatic system cancer	0.00154	0.00338	CcSEcCtD
Tinidazole—Urethral disorder—Vincristine—lymphatic system cancer	0.00153	0.00336	CcSEcCtD
Tinidazole—Hypersensitivity—Teniposide—lymphatic system cancer	0.00152	0.00334	CcSEcCtD
Tinidazole—Flushing—Carmustine—lymphatic system cancer	0.00152	0.00333	CcSEcCtD
Tinidazole—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00151	0.00332	CcSEcCtD
Tinidazole—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.00151	0.00331	CcSEcCtD
Tinidazole—Feeling abnormal—Fludarabine—lymphatic system cancer	0.0015	0.00328	CcSEcCtD
Tinidazole—Asthenia—Teniposide—lymphatic system cancer	0.00148	0.00325	CcSEcCtD
Tinidazole—Malaise—Bleomycin—lymphatic system cancer	0.00147	0.00322	CcSEcCtD
Tinidazole—Pruritus—Teniposide—lymphatic system cancer	0.00146	0.0032	CcSEcCtD
Tinidazole—Leukopenia—Bleomycin—lymphatic system cancer	0.00146	0.0032	CcSEcCtD
Tinidazole—Body temperature increased—Fludarabine—lymphatic system cancer	0.00144	0.00315	CcSEcCtD
Tinidazole—Malnutrition—Carmustine—lymphatic system cancer	0.00142	0.00312	CcSEcCtD
Tinidazole—Angiopathy—Vincristine—lymphatic system cancer	0.00142	0.00311	CcSEcCtD
Tinidazole—Diarrhoea—Teniposide—lymphatic system cancer	0.00141	0.0031	CcSEcCtD
Tinidazole—Myalgia—Bleomycin—lymphatic system cancer	0.00139	0.00304	CcSEcCtD
Tinidazole—Coma—Methotrexate—lymphatic system cancer	0.00138	0.00302	CcSEcCtD
Tinidazole—Discomfort—Bleomycin—lymphatic system cancer	0.00137	0.00301	CcSEcCtD
Tinidazole—Confusional state—Bleomycin—lymphatic system cancer	0.00134	0.00294	CcSEcCtD
Tinidazole—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00134	0.00293	CcSEcCtD
Tinidazole—Vomiting—Teniposide—lymphatic system cancer	0.00131	0.00288	CcSEcCtD
Tinidazole—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.0013	0.00286	CcSEcCtD
Tinidazole—Asthenia—Fludarabine—lymphatic system cancer	0.0013	0.00286	CcSEcCtD
Tinidazole—Rash—Teniposide—lymphatic system cancer	0.0013	0.00286	CcSEcCtD
Tinidazole—Dermatitis—Teniposide—lymphatic system cancer	0.0013	0.00285	CcSEcCtD
Tinidazole—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.0013	0.00284	CcSEcCtD
Tinidazole—Headache—Teniposide—lymphatic system cancer	0.00129	0.00284	CcSEcCtD
Tinidazole—Pruritus—Fludarabine—lymphatic system cancer	0.00129	0.00282	CcSEcCtD
Tinidazole—Leukopenia—Carmustine—lymphatic system cancer	0.00127	0.00279	CcSEcCtD
Tinidazole—Anorexia—Bleomycin—lymphatic system cancer	0.00127	0.00278	CcSEcCtD
Tinidazole—Diarrhoea—Fludarabine—lymphatic system cancer	0.00124	0.00272	CcSEcCtD
Tinidazole—Convulsion—Carmustine—lymphatic system cancer	0.00123	0.0027	CcSEcCtD
Tinidazole—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00123	0.00269	CcSEcCtD
Tinidazole—Nausea—Teniposide—lymphatic system cancer	0.00123	0.00269	CcSEcCtD
Tinidazole—Vertigo—Vincristine—lymphatic system cancer	0.00122	0.00268	CcSEcCtD
Tinidazole—Leukopenia—Vincristine—lymphatic system cancer	0.00122	0.00267	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00121	0.00266	CcSEcCtD
Tinidazole—Myalgia—Carmustine—lymphatic system cancer	0.00121	0.00266	CcSEcCtD
Tinidazole—Paraesthesia—Bleomycin—lymphatic system cancer	0.0012	0.00262	CcSEcCtD
Tinidazole—Malaise—Mitoxantrone—lymphatic system cancer	0.00119	0.00262	CcSEcCtD
Tinidazole—Dyspnoea—Bleomycin—lymphatic system cancer	0.00119	0.0026	CcSEcCtD
Tinidazole—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00119	0.0026	CcSEcCtD
Tinidazole—Convulsion—Vincristine—lymphatic system cancer	0.00118	0.00258	CcSEcCtD
Tinidazole—Confusional state—Carmustine—lymphatic system cancer	0.00117	0.00257	CcSEcCtD
Tinidazole—Decreased appetite—Bleomycin—lymphatic system cancer	0.00116	0.00254	CcSEcCtD
Tinidazole—Myalgia—Vincristine—lymphatic system cancer	0.00116	0.00254	CcSEcCtD
Tinidazole—Vomiting—Fludarabine—lymphatic system cancer	0.00115	0.00253	CcSEcCtD
Tinidazole—Convulsion—Mitoxantrone—lymphatic system cancer	0.00115	0.00251	CcSEcCtD
Tinidazole—Rash—Fludarabine—lymphatic system cancer	0.00115	0.00251	CcSEcCtD
Tinidazole—Dermatitis—Fludarabine—lymphatic system cancer	0.00114	0.00251	CcSEcCtD
Tinidazole—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00114	0.00249	CcSEcCtD
Tinidazole—Headache—Fludarabine—lymphatic system cancer	0.00114	0.00249	CcSEcCtD
Tinidazole—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00113	0.00247	CcSEcCtD
Tinidazole—Myalgia—Mitoxantrone—lymphatic system cancer	0.00113	0.00247	CcSEcCtD
Tinidazole—Discomfort—Mitoxantrone—lymphatic system cancer	0.00111	0.00244	CcSEcCtD
Tinidazole—Anorexia—Carmustine—lymphatic system cancer	0.00111	0.00243	CcSEcCtD
Tinidazole—Feeling abnormal—Bleomycin—lymphatic system cancer	0.0011	0.00241	CcSEcCtD
Tinidazole—Confusional state—Mitoxantrone—lymphatic system cancer	0.00109	0.00239	CcSEcCtD
Tinidazole—Nervous system disorder—Vincristine—lymphatic system cancer	0.00109	0.00239	CcSEcCtD
Tinidazole—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00109	0.00238	CcSEcCtD
Tinidazole—Nausea—Fludarabine—lymphatic system cancer	0.00108	0.00236	CcSEcCtD
Tinidazole—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00107	0.00235	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00106	0.00232	CcSEcCtD
Tinidazole—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00106	0.00232	CcSEcCtD
Tinidazole—Urticaria—Bleomycin—lymphatic system cancer	0.00106	0.00232	CcSEcCtD
Tinidazole—Anorexia—Vincristine—lymphatic system cancer	0.00106	0.00232	CcSEcCtD
Tinidazole—Body temperature increased—Bleomycin—lymphatic system cancer	0.00105	0.00231	CcSEcCtD
Tinidazole—Insomnia—Carmustine—lymphatic system cancer	0.00105	0.0023	CcSEcCtD
Tinidazole—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00105	0.0023	CcSEcCtD
Tinidazole—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00104	0.00229	CcSEcCtD
Tinidazole—Paraesthesia—Carmustine—lymphatic system cancer	0.00104	0.00229	CcSEcCtD
Tinidazole—Dyspnoea—Carmustine—lymphatic system cancer	0.00104	0.00227	CcSEcCtD
Tinidazole—Somnolence—Carmustine—lymphatic system cancer	0.00103	0.00226	CcSEcCtD
Tinidazole—Anorexia—Mitoxantrone—lymphatic system cancer	0.00103	0.00226	CcSEcCtD
Tinidazole—Ataxia—Methotrexate—lymphatic system cancer	0.00103	0.00226	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00101	0.00222	CcSEcCtD
Tinidazole—Decreased appetite—Carmustine—lymphatic system cancer	0.00101	0.00221	CcSEcCtD
Tinidazole—Insomnia—Vincristine—lymphatic system cancer	0.001	0.0022	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.001	0.0022	CcSEcCtD
Tinidazole—Paraesthesia—Vincristine—lymphatic system cancer	0.000996	0.00218	CcSEcCtD
Tinidazole—Constipation—Carmustine—lymphatic system cancer	0.000994	0.00218	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000985	0.00216	CcSEcCtD
Tinidazole—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000981	0.00215	CcSEcCtD
Tinidazole—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00097	0.00213	CcSEcCtD
Tinidazole—Decreased appetite—Vincristine—lymphatic system cancer	0.000965	0.00211	CcSEcCtD
Tinidazole—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000963	0.00211	CcSEcCtD
Tinidazole—Somnolence—Mitoxantrone—lymphatic system cancer	0.000961	0.00211	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000958	0.0021	CcSEcCtD
Tinidazole—Feeling abnormal—Carmustine—lymphatic system cancer	0.000958	0.0021	CcSEcCtD
Tinidazole—Fatigue—Vincristine—lymphatic system cancer	0.000957	0.0021	CcSEcCtD
Tinidazole—Asthenia—Bleomycin—lymphatic system cancer	0.000955	0.00209	CcSEcCtD
Tinidazole—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000951	0.00208	CcSEcCtD
Tinidazole—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000951	0.00208	CcSEcCtD
Tinidazole—Constipation—Vincristine—lymphatic system cancer	0.000949	0.00208	CcSEcCtD
Tinidazole—Pruritus—Bleomycin—lymphatic system cancer	0.000942	0.00206	CcSEcCtD
Tinidazole—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000939	0.00206	CcSEcCtD
Tinidazole—Fatigue—Mitoxantrone—lymphatic system cancer	0.000932	0.00204	CcSEcCtD
Tinidazole—Constipation—Mitoxantrone—lymphatic system cancer	0.000924	0.00203	CcSEcCtD
Tinidazole—Abdominal pain—Carmustine—lymphatic system cancer	0.000919	0.00201	CcSEcCtD
Tinidazole—Body temperature increased—Carmustine—lymphatic system cancer	0.000919	0.00201	CcSEcCtD
Tinidazole—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000907	0.00199	CcSEcCtD
Tinidazole—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000891	0.00195	CcSEcCtD
Tinidazole—Dysuria—Methotrexate—lymphatic system cancer	0.000885	0.00194	CcSEcCtD
Tinidazole—Neutropenia—Methotrexate—lymphatic system cancer	0.000885	0.00194	CcSEcCtD
Tinidazole—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000884	0.00194	CcSEcCtD
Tinidazole—Body temperature increased—Vincristine—lymphatic system cancer	0.000877	0.00192	CcSEcCtD
Tinidazole—Abdominal pain—Vincristine—lymphatic system cancer	0.000877	0.00192	CcSEcCtD
Tinidazole—Urticaria—Mitoxantrone—lymphatic system cancer	0.000859	0.00188	CcSEcCtD
Tinidazole—Hypersensitivity—Carmustine—lymphatic system cancer	0.000856	0.00188	CcSEcCtD
Tinidazole—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000854	0.00187	CcSEcCtD
Tinidazole—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000854	0.00187	CcSEcCtD
Tinidazole—Vomiting—Bleomycin—lymphatic system cancer	0.000847	0.00186	CcSEcCtD
Tinidazole—Drowsiness—Methotrexate—lymphatic system cancer	0.000844	0.00185	CcSEcCtD
Tinidazole—Rash—Bleomycin—lymphatic system cancer	0.00084	0.00184	CcSEcCtD
Tinidazole—Dermatitis—Bleomycin—lymphatic system cancer	0.000839	0.00184	CcSEcCtD
Tinidazole—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000837	0.00183	CcSEcCtD
Tinidazole—Asthenia—Carmustine—lymphatic system cancer	0.000834	0.00183	CcSEcCtD
Tinidazole—Stomatitis—Methotrexate—lymphatic system cancer	0.000823	0.0018	CcSEcCtD
Tinidazole—Hypersensitivity—Vincristine—lymphatic system cancer	0.000818	0.00179	CcSEcCtD
Tinidazole—Sweating—Methotrexate—lymphatic system cancer	0.000809	0.00177	CcSEcCtD
Tinidazole—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000796	0.00175	CcSEcCtD
Tinidazole—Asthenia—Vincristine—lymphatic system cancer	0.000796	0.00174	CcSEcCtD
Tinidazole—Diarrhoea—Carmustine—lymphatic system cancer	0.000795	0.00174	CcSEcCtD
Tinidazole—Nausea—Bleomycin—lymphatic system cancer	0.000791	0.00173	CcSEcCtD
Tinidazole—Asthenia—Mitoxantrone—lymphatic system cancer	0.000775	0.0017	CcSEcCtD
Tinidazole—Dizziness—Carmustine—lymphatic system cancer	0.000769	0.00168	CcSEcCtD
Tinidazole—Diarrhoea—Vincristine—lymphatic system cancer	0.000759	0.00166	CcSEcCtD
Tinidazole—Pharyngitis—Methotrexate—lymphatic system cancer	0.000752	0.00165	CcSEcCtD
Tinidazole—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000748	0.00164	CcSEcCtD
Tinidazole—Urethral disorder—Methotrexate—lymphatic system cancer	0.000743	0.00163	CcSEcCtD
Tinidazole—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000739	0.00162	CcSEcCtD
Tinidazole—Vomiting—Carmustine—lymphatic system cancer	0.000739	0.00162	CcSEcCtD
Tinidazole—Dizziness—Vincristine—lymphatic system cancer	0.000734	0.00161	CcSEcCtD
Tinidazole—Rash—Carmustine—lymphatic system cancer	0.000733	0.00161	CcSEcCtD
Tinidazole—Dermatitis—Carmustine—lymphatic system cancer	0.000732	0.0016	CcSEcCtD
Tinidazole—Headache—Carmustine—lymphatic system cancer	0.000728	0.0016	CcSEcCtD
Tinidazole—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000717	0.00157	CcSEcCtD
Tinidazole—Vomiting—Vincristine—lymphatic system cancer	0.000706	0.00155	CcSEcCtD
Tinidazole—Rash—Vincristine—lymphatic system cancer	0.0007	0.00153	CcSEcCtD
Tinidazole—Dermatitis—Vincristine—lymphatic system cancer	0.000699	0.00153	CcSEcCtD
Tinidazole—Headache—Vincristine—lymphatic system cancer	0.000695	0.00152	CcSEcCtD
Tinidazole—Nausea—Carmustine—lymphatic system cancer	0.00069	0.00151	CcSEcCtD
Tinidazole—Angiopathy—Methotrexate—lymphatic system cancer	0.000688	0.00151	CcSEcCtD
Tinidazole—Vomiting—Mitoxantrone—lymphatic system cancer	0.000687	0.00151	CcSEcCtD
Tinidazole—Immune system disorder—Methotrexate—lymphatic system cancer	0.000685	0.0015	CcSEcCtD
Tinidazole—Rash—Mitoxantrone—lymphatic system cancer	0.000681	0.00149	CcSEcCtD
Tinidazole—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000681	0.00149	CcSEcCtD
Tinidazole—Headache—Mitoxantrone—lymphatic system cancer	0.000677	0.00148	CcSEcCtD
Tinidazole—Malnutrition—Methotrexate—lymphatic system cancer	0.00066	0.00145	CcSEcCtD
Tinidazole—Nausea—Vincristine—lymphatic system cancer	0.000659	0.00144	CcSEcCtD
Tinidazole—Dysgeusia—Methotrexate—lymphatic system cancer	0.000646	0.00142	CcSEcCtD
Tinidazole—Nausea—Mitoxantrone—lymphatic system cancer	0.000642	0.00141	CcSEcCtD
Tinidazole—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000612	0.00134	CcSEcCtD
Tinidazole—Malaise—Methotrexate—lymphatic system cancer	0.000595	0.0013	CcSEcCtD
Tinidazole—Vertigo—Methotrexate—lymphatic system cancer	0.000593	0.0013	CcSEcCtD
Tinidazole—Leukopenia—Methotrexate—lymphatic system cancer	0.000591	0.00129	CcSEcCtD
Tinidazole—Convulsion—Methotrexate—lymphatic system cancer	0.000572	0.00125	CcSEcCtD
Tinidazole—Myalgia—Methotrexate—lymphatic system cancer	0.000562	0.00123	CcSEcCtD
Tinidazole—Arthralgia—Methotrexate—lymphatic system cancer	0.000562	0.00123	CcSEcCtD
Tinidazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000558	0.00122	CcSEcCtD
Tinidazole—Discomfort—Methotrexate—lymphatic system cancer	0.000555	0.00122	CcSEcCtD
Tinidazole—Confusional state—Methotrexate—lymphatic system cancer	0.000543	0.00119	CcSEcCtD
Tinidazole—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000528	0.00116	CcSEcCtD
Tinidazole—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000527	0.00116	CcSEcCtD
Tinidazole—Skin disorder—Methotrexate—lymphatic system cancer	0.000523	0.00115	CcSEcCtD
Tinidazole—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000521	0.00114	CcSEcCtD
Tinidazole—Anorexia—Methotrexate—lymphatic system cancer	0.000513	0.00112	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000491	0.00108	CcSEcCtD
Tinidazole—Insomnia—Methotrexate—lymphatic system cancer	0.000487	0.00107	CcSEcCtD
Tinidazole—Paraesthesia—Methotrexate—lymphatic system cancer	0.000483	0.00106	CcSEcCtD
Tinidazole—Dyspnoea—Methotrexate—lymphatic system cancer	0.00048	0.00105	CcSEcCtD
Tinidazole—Somnolence—Methotrexate—lymphatic system cancer	0.000479	0.00105	CcSEcCtD
Tinidazole—Dyspepsia—Methotrexate—lymphatic system cancer	0.000474	0.00104	CcSEcCtD
Tinidazole—Decreased appetite—Methotrexate—lymphatic system cancer	0.000468	0.00103	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000465	0.00102	CcSEcCtD
Tinidazole—Fatigue—Methotrexate—lymphatic system cancer	0.000464	0.00102	CcSEcCtD
Tinidazole—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000444	0.000972	CcSEcCtD
Tinidazole—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.00044	0.000965	CcSEcCtD
Tinidazole—Urticaria—Methotrexate—lymphatic system cancer	0.000428	0.000937	CcSEcCtD
Tinidazole—Abdominal pain—Methotrexate—lymphatic system cancer	0.000426	0.000933	CcSEcCtD
Tinidazole—Body temperature increased—Methotrexate—lymphatic system cancer	0.000426	0.000933	CcSEcCtD
Tinidazole—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000397	0.000869	CcSEcCtD
Tinidazole—Asthenia—Methotrexate—lymphatic system cancer	0.000386	0.000847	CcSEcCtD
Tinidazole—Pruritus—Methotrexate—lymphatic system cancer	0.000381	0.000835	CcSEcCtD
Tinidazole—Diarrhoea—Methotrexate—lymphatic system cancer	0.000368	0.000807	CcSEcCtD
Tinidazole—Dizziness—Methotrexate—lymphatic system cancer	0.000356	0.00078	CcSEcCtD
Tinidazole—Vomiting—Methotrexate—lymphatic system cancer	0.000342	0.00075	CcSEcCtD
Tinidazole—Rash—Methotrexate—lymphatic system cancer	0.000339	0.000744	CcSEcCtD
Tinidazole—Dermatitis—Methotrexate—lymphatic system cancer	0.000339	0.000743	CcSEcCtD
Tinidazole—Headache—Methotrexate—lymphatic system cancer	0.000337	0.000739	CcSEcCtD
Tinidazole—Nausea—Methotrexate—lymphatic system cancer	0.00032	0.000701	CcSEcCtD
